Revamp Medical

Revamp Medical, founded in 2016, focuses on addressing the urgent unmet needs of patients suffering from acute heart failure, a condition that leads to over one million annual hospital admissions in the United States and incurs significant healthcare costs. The company has developed the Doraya™ catheter, a patented device designed to regulate vascular hemodynamics in these patients. This innovative solution targets issues such as diuretic resistance by managing preload and reducing central venous pressure, ultimately enhancing the efficacy of diuretics and facilitating progressive decongestion. Revamp Medical is backed by a team of experienced professionals with a strong background in medical technology startups, positioning the company to deliver an easily adoptable treatment option that addresses a critical gap in heart failure care.